Iambic Therapeutics, Inc. — Form D

Iambic Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-21. The offering totals $125.0M, of which $99.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-11-21
• Form: D
• Accession: 0001997038-25-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $125.0M
• Amount sold: $99.3M
• Remaining: $25.7M
• Investors: 22
• Date of first sale: 2025-11-06
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-564708

Issuer

• Name: Iambic Therapeutics, Inc.
• CIK: 0001997038
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 5627 OBERLIN DRIVE, SUITE 120 5627 Oberlin Drive, Suite 120, SAN DIEGO, CA, 92121
• Phone: (626) 592-2520

Officers, directors & promoters (28)

Showing 25 of 28 people.

Other filings by this issuer (5)

More

• CIK 1997038 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search